Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Closed
Phase 2/3
This trial is for people with advanced non small cell lung cancer that can’t be treated with the aim to cure. And who:
have certain changes (mutations) in their lung cancer cells
are having a targeted cancer drug
have 5 or fewer areas of cancer that have now stopped responding to targeted cancer treatment
Cancer Research UK supports this trial.
Recruitment start: 27 November 2017
Recruitment end: 17 July 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Fiona McDonald
Cancer Research UK
European Organisation for Research and Treatment of Cancer (EORTC)
ICR Clinical Trials and Statistics Unit (ICR-CTSU)
NHS England
Radiotherapy Trials Quality Assurance (RTTQA)
This is Cancer Research UK trial number CRUK/16/020.
Last reviewed: 18 July 2023
CRUK internal database number: 15118